Yahoo Web Search

Search results

1. • 

     After Patient Death, Salarius Stops Enrollment In Seclidemstat Trial For Soft Tissue Cancer

     Benzinga via Yahoo Finance· 2 years ago

     Per protocol design, Salarius Pharmaceuticals Inc (NASDAQ: SLRX) is voluntarily pausing new patient...

2. • 

     10 Market-Moving Stocks to Watch Today

     Insider Monkey via Yahoo Finance· 2 years ago

     In this article, we will discuss 10 market-moving stocks to watch on Thursday. To take a look at some more stocks that are trending, go to 5...

3. • Salarius: Q1 Earnings Snapshot

     AP Finance via Yahoo Finance· 11 months ago

     HOUSTON (AP) — HOUSTON (AP) — Salarius Pharmaceuticals, Inc. (SLRX) on Thursday reported a loss of $5.3 million in its first quarter. The Houston-based company said it had a loss of $2.23 per ...